FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for benztropine mesylate, submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Parkinsonism
• Dystonia
• Extrapyramidal Disorders
• Parkinson Disease

Drugs mentioned

• Benztropine Mesylate (benztropine mesylate)

Snippet

SUPPL AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)